[email protected] (M= Ni and Cu): Two green, novel and efficient catalysts for the one-pot synthesis of 5-substituted tetrazole and polyhydroquinoline derivatives
-
Add time:07/13/2019 Source:sciencedirect.com
The development of highly efficient and green catalyst for the one-pot synthesis of 5-substituted tetrazole and polyhydroquinoline derivatives is an extremely important and ground challenging area in organic chemistry. In this study, two catalysts were prepared by the immobilization of Ni and Cu on ordered mesoporous silica (SBA-15) coated with glycine. The proposed catalysts were characterized by FT-IR, XRD, BET, TGA, EDX, and ICP-OES studies and were successfully applied in the synthesis of 5-substituted tetrazoles and polyhydroquinoline derivatives. This designed protocol offers several advantages including the use of commercially available and inexpensive materials, simple procedure, short reaction times, high yield, and easily separable and reusable catalyst.
We also recommend Trading Suppliers and Manufacturers of 5-(4-chlorophenyl)-1-(3,4-dimethoxyphenyl)-3a,6a-dihydrosprio[1H-furo[3,4-c]pyrrole-3,2'-(1'H)-indene]-1',3',4,6(2'H,3H,5H)-tetrone (cas 371201-77-3). Pls Click Website Link as below: cas 371201-77-3 suppliers
Prev:Synthesis and anticonvulsant activity of some 2-pyrazolines derived from chalcones
Next:Synthesis, biological evaluation and docking study of a new series of di-substituted benzoxazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Synthesis and cytotoxic studies of novel 5-phenylisatin derivatives and their anti-migration and anti-angiogenic evaluation07/15/2019
- Synthesis, biological evaluation and docking study of a new series of di-substituted benzoxazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents07/14/2019
- Synthesis and anticonvulsant activity of some 2-pyrazolines derived from chalcones07/12/2019
- Discovery of novel human inosine 5′-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents07/11/2019


